American Heart Journal

American Heart Journal is a peer reviewed cardiology journal that publishes the primary clinical investigation, scholarly review and opinion of cardiovascular medicine, issued monthly by Elsevier, with a 2025 impact factor of 3.4 in the cardiac and cardiovascular systems category of the journal citation reports and a CiteScore of 6.7.《美国心脏杂志》是一份同行评审的心脏病学期刊，刊发心血管医学的原创临床研究、学术综述与观点评论，由 Elsevier 每月出版，2025 年在期刊引证报告的心脏病学与心血管系统类目的影响因子为 3.4，引文得分为 6.7。

Scope

• The publisher states that the title considers for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease, and its goal is to give the reader primary investigation, scholarly review and opinion concerning the practice of cardiovascular medicine.出版方写明，该刊考虑发表以心血管疾病这一宽泛学科为题材的论文，其目标是向读者提供心血管医学实践方面的原创研究、学术综述与观点。

• Three kinds of report are singled out for encouragement because they are seldom seen in cardiovascular journals, namely negative clinical studies, reports on study designs and studies on the organisation of medical care.出版方特别鼓励三类在心血管期刊中不常见的报告，分别是阴性临床研究、研究设计报告以及关于医疗组织方式的研究。

• Individual case reports and original articles resting on bench laboratory or animal research are not accepted.该刊不收单个病例报告，也不收以台架实验室或动物实验为基础的原创论文。

• The regular sections are clinical investigations, trial designs, research letters, letters to the editor, editorials and supplements, and a manuscript has to name its intended section on the title page.常规板块分为临床研究、试验设计、研究短文、致编辑函、社论与增刊，投稿时须在标题页写明拟投的板块名称。

• Clinical investigations are meant to be original and in depth, whereas trial designs describe study protocols together with the conceptual issues behind the hypotheses, the methodology and the planned analysis.临床研究板块要求原创且深入，试验设计板块则要求写明研究方案以及假设背后的概念问题、方法学与计划的统计分析。

• A trial design paper is judged in part on whether the investigators are likely to complete the trial as planned, so it should give the target sample size and a timeline for enrolment and follow up.试验设计论文的评估依据之一是研究者能否按计划完成试验，因此须给出目标样本量以及入组与随访的时间表。

• Research letters are short original reports of up to 1500 words and no more than 12 references, with room for three figures or tables and with online supplementary material permitted.研究短文是简短的原创报告，字数上限 1500 词，参考文献不超过 12 条，可放三幅图或表，也允许提供在线补充材料。

• Letters to the editor deal with material published recently in the title, and the authors of the paper in question are asked for a reply that is published together with the letter.致编辑函针对该刊近期发表的论文内容，被质疑论文的作者会被要求回应，回应与来信一并刊出。

• Supplements are accepted on the importance of the topic, the expertise of the participants and the scientific quality of the papers, all of them go through peer review, and any proprietary sponsorship has to be declared.增刊按选题的重要性、参与者���专业性与论文的科学质量决定是否采用，全部增刊都走同行评审，任何商业赞助都必须声明。

• A manuscript on the design or the results of a randomised clinical trial must give the registration site and the registration number in the methods section, and the journal follows the registration guidelines of the International Committee of Medical Journal Editors.涉及随机临床试验设计或结果的稿件，必须在方法部分给出注册网址与注册号，该刊遵循国际医学期刊编辑委员会的临床试验注册准则。

• Trials have to be registered in a public registry at or before the onset of patient enrolment, while purely observational studies in which the intervention is not at the discretion of the investigator do not need registration.试验必须在患者入组开始之前或同时在公开注册库登记，而干预措施不由研究者决定的纯观察性研究则无须登记。

• The subject area given by the publisher is cardiology and cardiovascular medicine, and the Elsevier subject list is short because the title is aimed squarely at the clinic and the trial.出版方给出的学科范围是心脏病学与心血管医学，Elsevier 的学科列表很短，说明该刊直指临床与试验本身。

• Five services are named on the official abstracting and indexing list, including Scopus and Medline, along with the Science Citation Index Expanded, the Scimago Journal Rank and SNIP.官方收录名单列出五项服务，其中包括 Scopus 与 Medline，以及科学引文索引扩展版、Scimago 期刊排名与 SNIP。

• The national medical catalogue adds the library databases behind those services, recording full MEDLINE coverage from volume 70 number 4 of October 1965 as well as PubMed coverage from the same point, together with the older printed indexes of Index Medicus and the Abridged Index Medicus.国家医学目录在上述服务之外还登记了背后的文献库，记下 MEDLINE 自第 70 卷第 4 期即 1965 年 10 月起的全文收录，PubMed 起点相同，并列出更早的印本索引 Index Medicus 与 Abridged Index Medicus。

• The publisher reports an acceptance route in which a first decision arrives four days after submission and a decision following review after forty three days, with acceptance typically one hundred and five days after submission and the online record four days after acceptance.出版方报告的处理节奏是投稿后四天给出首轮决定，评审后四十三天给出决定，通常在投稿后一百零五天录用，接受后四天上线。

• An article published open access is charged 3960 US dollars excluding taxes, whereas a subscriber pays nothing and the published record is available at once to subscribers.以开放获取方式发表的论文需缴纳 3960 美元的处理费且不含税，订阅者则不需付费，出版的内容立即对订户开放。

• A companion title for open access cardiology research and practice is listed on the same platform with a CiteScore of 3.3 and an impact factor of 2.3.同一平台上还列有一份面向心脏病学研究与实践的开放获取姊妹刊，其引文得分为 3.3，影响因子为 2.3。

History

• The opening volume appeared in October 1925, and the publisher's own archive still carries the issue with its front matter and the pages of that first number.开卷第一期出版于 1925 年 10 月，出版方的存档至今仍留着这一期的卷首部分与全部页码。

• The catalogue of the national medical library records that the title was issued by the American Heart Association from 1925 to 1949 and gives the first imprint as St. Louis with the publisher Mosby.国家医学图书馆的目录记下该刊在 1925 年至 1949 年间由美国心脏协会发行，创刊印地记作圣路易斯的 Mosby。

• The earliest item in the publisher's retrospective archive belongs to that very first issue of October 1925, and among its front matter is a report of the meeting of the association held in May of that year.出版方回溯存档中最早的一条属于 1925 年 10 月的创刊号，其卷首部分有一篇关于协会当年 5 月那次会议的报道。^[1]

• For its first decade the title came out as one volume a year carrying six issues, and the volumes straddled the calendar year, so that 1926 held volumes 1 and 2 and 1927 held volumes 2 and 3.头十年该刊每年出一卷，每卷六期，而且卷号跨年，因此 1926 年包含第 1 卷与第 2 卷，1927 年包含第 2 卷与第 3 卷。

• The table of volumes the publisher keeps for the archive shows the single year of volume 10 in 1935 and two volumes a year from 1936 onwards, with volume 33 running from January to June 1947 and volume 34 from July to December of the same year.出版方为存档保留的卷号表显示第 10 卷单独对应 1935 年，自 1936 年起每年两卷，其中第 33 卷自 1947 年 1 月至 6 月，第 34 卷则自同年 7 月至 12 月。

• Twelve issues a year therefore came out of each of those paired volumes, which is the rhythm the title still keeps, with one volume for each month from 2016 onwards.由此每对卷号一年出十二期，这正是该刊至今保持的节奏，自 2016 年起每月一卷。

• The publisher's table records volume 171 to volume 182 for 2016 and then advances twelve volumes every year, so that 2023 carries volumes 255 to 266, 2025 carries volumes 279 to 290 and 2026 carries volumes 291 to 302.出版方的卷号表记下 2016 年为第 171 卷至第 182 卷，此后每年递增十二卷，因此 2023 年为第 255 卷至第 266 卷，2025 年为第 279 卷至第 290 卷，2026 年为第 291 卷至第 302 卷。

• The medical catalogue corroborates that reading, placing volume 279 in January 2025, volume 291 in January 2026 and volume 301 in November 2026.医学目录印证了这一读法，把第 279 卷定在 2025 年 1 月，第 291 卷定在 2026 年 1 月，第 301 卷定在 2026 年 11 月。

• The next volume is already running, with volume 303 marked as in progress for January 2027.下一卷已经在进行之中，第 303 卷被标为 2027 年 1 月的进行中卷。

• Coverage by MEDLINE began with volume 70 number 4 in October 1965, so the library record runs for more than sixty years of the title's life.MEDLINE 的收录自 1965 年 10 月的第 70 卷第 4 期开始，目录里的这条记录因此已覆盖该刊六十余年的生涯。

• The imprint on the archive is still the Saint Louis house of Mosby, while the current imprint carries the copyright of Elsevier, which shows the route by which the title passed from the association and its St. Louis publisher into the present group.存档上的印地仍是圣路易斯的 Mosby，现在的版权则署 Elsevier，刊物的传承路径由此可见。

• The publisher has opened a series of conference collections, and the platform lists the abstracts of the tenth gathering on diabetes and the heart for December 2026 and those of the ninth and the eighth for December 2025 and December 2024.出版方开设了系列会议文集，平台上列有第十届糖尿病与心脏会议在 2026 年 12 月的论文摘要，第九届与第八届则分别对应 2025 年 12 月与 2024 年 12 月。

• A more recent collection on the burgeoning field of cardio obstetrics was assembled by (William Schnettler), (Sarah Goldstein) and (Jerome Jeffrey Federspiel) and was released in January 2026.较近的一份专辑聚焦正在兴起的产科与心脏病交叉方向，由（William Schnettler）、（Sarah Goldstein）与（Jerome Jeffrey Federspiel）组稿，于 2026 年 1 月推出。

• The impact factor has drifted down from the levels of the early 2020s, standing at 3.4 for 2025 after 3.5 for 2024 and 3.7 for 2023, with 5.099 recorded for 2022 and 4.749 for 2021.该刊影响因子从 2020 年代初的水平回落，2025 年为 3.4，2024 年 3.5，2023 年 3.7，而 2022 年记为 5.099，2021 年记为 4.749。

• The citation score has moved the other way, and the publisher now reports 6.7 against a 3.4 impact factor.引文得分则朝相反方向变化，出版方现在报出的引文得分为 6.7，而影响因子为 3.4。

• A companion open access title for cardiology research and practice runs beside it on the same platform, and the two are presented together on the publisher's journal page.一份面向心脏病学研究与实践的开放获取姊妹刊与它并列在同一个平台上，出版方的期刊页把两者一并呈现。

• The archive of the publisher still carries the whole run back to 1925, and the earliest issues remain readable there in the same pagination the original print used.出版方的存档仍保存着自 1925 年起的全部卷期，最早的期次在那里仍按当年印本的页码可读。

Editors

• The editor in chief is (Daniel B. Mark), who sits at the Duke University School of Medicine in Durham, North Carolina.现任主编是（Daniel B. Mark），任职于北卡罗来纳州达勒姆的杜克大学医学院。

• The executive editor is (Patricia K. Hodgson) of the Duke Clinical Research Institute, and the managing editor is (Melanie R. Daniels), who is based in the same city.执行编辑是杜克临床研究所的（Patricia K. Hodgson），执行主编是在同一座城市工作的（Melanie R. Daniels）。

• Fourteen associate editors work with them, among them (Thomas M. Bashore) and (Gerald S. Bloomfield) at Duke, (Derek Chew) at the University of Calgary, (Justin Ezekowitz) and (Sean Van Diepen) at the University of Alberta Hospital and (Emil Fosbol) at the Heart Centre in Copenhagen.与他们共事的副主编有十四位，其中（Thomas M. Bashore）与（Gerald S. Bloomfield）在杜克，（Derek Chew）在卡尔加里大学，（Justin Ezekowitz）与（Sean Van Diepen）在阿尔伯塔大学医院，（Emil Fosbol）在哥本哈根的心脏中心。

• The rest of the associate editors are (J. Kevin Harrison) and (Kevin D. Hill) at Duke, (Paul A. Heidenreich) at the VA Palo Alto Health Care System, (Angela Lowenstern) at Vanderbilt, (Robert McGarrah) at Duke, (Michael G. Nanna) at the Yale School of Medicine, (Sudarshan Rajagopal) at Duke and (Emily P. Zeitler) at Dartmouth Hitchcock.其余副主编为在杜克的（J. Kevin Harrison）与（Kevin D. Hill），在帕洛阿尔托退伍军人医疗系统的（Paul A. Heidenreich），在范德堡大学的（Angela Lowenstern），在杜克的（Robert McGarrah），在耶鲁大学医学院的（Michael G. Nanna），在杜克的（Sudarshan Rajagopal），以及在达特茅斯希区克医疗中心的（Emily P. Zeitler）。

• The board itself is large, with 251 editors and editorial board members drawn from 19 countries and regions, of whom 204 are from the United States, 16 from Canada, 4 each from Australia, Denmark and the United Kingdom, 3 from Italy, 2 each from Brazil, the Netherlands and Sweden, and one from each of nine further countries.编委规模很大，共有来自 19 个国家与地区的 251 名编辑与编委成员，其中国内 204 人，加拿大 16 人，澳大利亚、丹麦与英国各 4 人，意大利 3 人，巴西、荷兰与瑞典各 2 人，另有九个国家各有一人。

• Review is single anonymised, so the referees know who wrote the manuscript, and a submission is first assessed by the editors before it is typically sent to a minimum of two reviewers for an independent expert judgement of the scientific quality.评审采用单匿名方式，审稿人知道作者身份，稿件先由编辑评估，合适时通常再送至少两位审稿人就科学质量作独立的专家判断。

• The editors decide whether to accept or reject, and they are expected to stay out of the decision on a paper they wrote themselves, on a paper by family members or colleagues, and on a paper relating to products or services in which they have an interest.是否录用由编辑决定，而编辑不参与裁定自己写的论文、家人或同事写的论文，以及与自身有利益关联的产品或服务有关的论文。

• An author who disagrees may appeal once, and the appeal has to follow the procedure set out in the publisher's appeal policy, after which the decision stands.作者若不服可申诉一次，申诉须遵循出版方的申诉政策程序，之后结果即为最终结果。

• Special issues follow the same peer review process as regular submissions, except that a guest editor may send the papers out to the reviewers and recommend a decision, while the journal editor keeps an eye on the process throughout.专辑沿用与常规投稿相同的同行评审流程，只是客座编辑可以把稿件送审并给出处理建议，期刊编辑则全程督看这一过程。

• Letters to the editor are sent by e-mail to the managing editor, and a request for a reply goes to the authors of the paper under discussion.致编辑函以电子邮件发给执行主编，而请原作者回应的一步则交给被讨论论文的作者。

• Proposals for supplements are sent by e-mail to (Craig Smith), and the publisher asks that any proprietary sponsorship be stated plainly.增刊的组稿方案以电子邮件发给（Craig Smith），出版方要求把任何商业赞助写明。

• Authors must declare the use of generative artificial intelligence tools in preparing a manuscript, and the tools may only be applied under human oversight and control.作者须在准备稿件时声明使用过生成式人工智能工具，且这些工具只能在人工监督与掌控之下使用。

• Preprints may be shared on a preprint server, and the publisher does not treat such sharing as prior publication.预印本可发布在预印本服务器上，出版方不把这种分享视作既往发表。

• The library citation report keeps a single category entry for the title, the cardiac and cardiovascular systems area, and reads a second quartile placement for 2025 at rank 74 among 237 journals.馆内引证报告为该刊只保留一条类目记录，就是心脏病学与心血管系统方向，2025 年记作第二区，237 种期刊中排第 74 位。

• The editor in chief has used the editorial pages to announce a new partnership between the journal and a society in the field of critical care cardiology, and the announcement appeared as an editorial coauthored by (Jason N. Katz) and the editor in chief.主编曾借社论版面宣布该刊与重症心脏病学方向的学会建立新的合作关系，这一宣布以（Jason N. Katz）与主编合著的社论形式刊出。^[2]

• The publisher asks authors to state the availability of their data at submission, and says that such a statement will appear with the published article.出版方请作者在投稿时说明数据可否获取，并告知这条说明会与论文一同呈现。

• A single corresponding author is designated for every manuscript, and the publishing agreement that follows acceptance is decided on the basis of that author's affiliation.每篇稿件都须指定一位通讯作者，接受之后签署的出版协议以该作者的所属机构为依据。

• Deliberate postponement of a paper has to be arranged with the editorial office as early as possible, and once the agreed period has passed the article may be published at any time.有意推迟发表须尽早与编辑部商定，约定期限一旦过去，论文即可能随时刊出。